Trends in Prostate Cancer Diagnosis During The COVID-19 Pandemic: Single-Institution Experience
The aim of this study was to compare the number of biopsy and surgical procedures on prostate, as well as the number of newly diagnosed, histologically confirmed cases of prostate cancer during the COVID-19 pandemic at Zagreb University Hospital Center (UHC). We retrospectively collected and proc...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2023-01-01
|
| Series: | Acta Clinica Croatica |
| Subjects: | |
| Online Access: | https://hrcak.srce.hr/file/445959 |
| Summary: | The aim of this study was to compare the number of biopsy and surgical procedures
on prostate, as well as the number of newly diagnosed, histologically confirmed cases of prostate cancer
during the COVID-19 pandemic at Zagreb University Hospital Center (UHC). We retrospectively
collected and processed a total of 1344 histopathologic findings of the prostate at the Zagreb UHC. Our
results show that during the COVID-19 pandemic, there was a statistically significant decrease in the
absolute number of biopsy and surgical procedures on prostate at Zagreb UHC, and so was the number
of newly diagnosed, histologically confirmed cases of prostate cancer. During the observed time of the
pandemic (March 19, 2020 to December 31, 2020), there was a 37.5% decrease in the absolute number
of newly diagnosed prostate cancer cases compared to the same period of the previous year (March 19,
2019 to December 31, 2019). To our knowledge, this is the first study of this kind that is based on the
number of prostate cancer diagnoses in Croatia. By observing the early period of the pandemic, our
results provide important guidelines for monitoring and understanding the long-term consequences of
the pandemic on the prostate cancer morbidity and mortality. |
|---|---|
| ISSN: | 0353-9466 1333-9451 |